Legend Biotech to Establish New, State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia

Core Insights - Legend Biotech Corporation is establishing a new R&D facility in Philadelphia, Pennsylvania, to enhance its next-generation cell therapies portfolio [1][2] - The new facility will support Legend's commitment to R&D and strengthen its position in cell therapy innovation [2][3] Company Expansion - The Philadelphia facility will be 31,000 square feet and is expected to be completed in Q3 2025 [2] - Legend Biotech currently has over 1,200 employees in the U.S. and plans to employ 55 full-time staff at the new site [2] Strategic Importance - The new facility will allow Legend to leverage its proximity to leading academic institutions in Philadelphia, enhancing collaboration and innovation in medical breakthroughs [3] - The expansion builds on Legend's existing R&D presence in the U.S., including a facility in Piscataway, New Jersey [2]